Annual Book Value
$48.05 B
+$45.75 B+0.77%
31 March 2024
Summary:
Takeda Pharmaceutical Company Limited annual book value is currently $48.05 billion, with the most recent change of +$45.75 billion (+0.77%) on 31 March 2024. During the last 3 years, it has risen by +$1.16 billion (+2.48%). TAK annual book value is now at all-time high.TAK Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Book Value
$48.46 B
-$243.70 K0.00%
01 September 2024
Summary:
Takeda Pharmaceutical Company Limited quarterly book value is currently $48.46 billion, with the most recent change of -$243.70 thousand (0.00%) on 01 September 2024. Over the past year, it has increased by +$1.13 billion (+2.39%). TAK quarterly book value is now at all-time high.TAK Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TAK Book Value Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.8% | +2.4% |
| 3 y3 years | +2.5% | +1.9% |
| 5 y5 years | +2.8% | +7.5% |
TAK Book Value High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +3.2% | at high | +4.8% |
| 5 y | 5 years | at high | +9.9% | at high | +11.3% |
| alltime | all time | at high | +399.6% | at high | +186.0% |
Takeda Pharmaceutical Company Limited Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $48.46 B(-0.0%) |
| June 2024 | - | $48.46 B(+0.8%) |
| Mar 2024 | $48.05 B(+0.8%) | $48.05 B(+0.5%) |
| Dec 2023 | - | $47.81 B(+1.0%) |
| Sept 2023 | - | $47.33 B(-1.0%) |
| June 2023 | - | $47.80 B(+0.2%) |
| Mar 2023 | $47.69 B(+2.4%) | $47.69 B(+1.2%) |
| Dec 2022 | - | $47.10 B(+1.4%) |
| Sept 2022 | - | $46.47 B(+0.5%) |
| June 2022 | - | $46.25 B(-0.7%) |
| Mar 2022 | $46.56 B(-0.7%) | $46.56 B(+0.5%) |
| Dec 2021 | - | $46.33 B(-2.6%) |
| Sept 2021 | - | $47.56 B(+0.4%) |
| June 2021 | - | $47.39 B(+1.0%) |
| Mar 2021 | $46.89 B(+7.3%) | $46.89 B(+4.3%) |
| Dec 2020 | - | $44.94 B(+1.9%) |
| Sept 2020 | - | $44.12 B(+1.3%) |
| June 2020 | - | $43.56 B(-0.3%) |
| Mar 2020 | $43.71 B(-6.5%) | $43.71 B(-2.3%) |
| Dec 2019 | - | $44.74 B(-0.7%) |
| Sept 2019 | - | $45.07 B(-0.1%) |
| June 2019 | - | $45.14 B(-3.4%) |
| Mar 2019 | $46.74 B(+148.7%) | $46.74 B(+153.0%) |
| Dec 2018 | - | $18.47 B(-3.1%) |
| Sept 2018 | - | $19.07 B(+3.2%) |
| June 2018 | - | $18.49 B(-1.6%) |
| Mar 2018 | $18.80 B(+10.9%) | $18.80 B(+0.2%) |
| Dec 2017 | - | $18.75 B(+1.1%) |
| Sept 2017 | - | $18.54 B(+3.1%) |
| June 2017 | - | $17.98 B(+6.1%) |
| Mar 2017 | $16.94 B(-2.3%) | $16.94 B(-0.6%) |
| Dec 2016 | - | $17.04 B(-5.2%) |
| Sept 2016 | - | $17.97 B(+2.2%) |
| June 2016 | - | $17.59 B(+1.5%) |
| Mar 2016 | $17.34 B | $17.34 B(-0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | - | $17.42 B(-1.5%) |
| Sept 2015 | - | $17.68 B(+0.2%) |
| June 2015 | - | $17.65 B(-0.9%) |
| Mar 2015 | $17.80 B(-25.8%) | $17.80 B(-15.0%) |
| Dec 2014 | - | $20.95 B(-7.0%) |
| Sept 2014 | - | $22.52 B(-4.4%) |
| June 2014 | - | $23.55 B(-1.9%) |
| Mar 2014 | $24.01 B(-0.6%) | $24.01 B(+5.7%) |
| Dec 2013 | - | $22.71 B(-2.6%) |
| Sept 2013 | - | $23.33 B(+3.9%) |
| June 2013 | - | $22.46 B(-7.0%) |
| Mar 2013 | $24.15 B(-5.7%) | $24.15 B(+0.7%) |
| Dec 2012 | - | $23.98 B(-2.7%) |
| Sept 2012 | - | $24.64 B(+3.4%) |
| June 2012 | - | $23.83 B(-6.9%) |
| Mar 2012 | $25.60 B(+1.8%) | $25.60 B(+3.8%) |
| Dec 2011 | - | $24.67 B(-4.7%) |
| Sept 2011 | - | $25.90 B(+0.9%) |
| June 2011 | - | $25.66 B(+2.1%) |
| Mar 2011 | $25.14 B(+10.9%) | $25.14 B(+0.1%) |
| Dec 2010 | - | $25.13 B(+1.8%) |
| Sept 2010 | - | $24.68 B(+7.0%) |
| June 2010 | - | $23.06 B(+1.7%) |
| Mar 2010 | $22.68 B(+11.6%) | $22.68 B(+2.2%) |
| Dec 2009 | - | $22.18 B(-2.5%) |
| Sept 2009 | - | $22.75 B(+12.0%) |
| Mar 2009 | $20.32 B(-11.0%) | $20.32 B(-1.8%) |
| Dec 2008 | - | $20.68 B |
| Mar 2008 | $22.83 B(+11.2%) | - |
| Mar 2007 | $20.52 B(+2.9%) | - |
| Mar 2006 | $19.94 B(+6.8%) | - |
| Mar 2005 | $18.67 B(+9.3%) | - |
| Mar 2004 | $17.09 B(+28.6%) | - |
| Mar 2003 | $13.28 B(+24.3%) | - |
| Mar 2002 | $10.68 B(+11.1%) | - |
| Mar 2001 | $9.62 B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual book value?
- What is the all time high annual book value for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual book value year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly book value?
- What is the all time high quarterly book value for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly book value year-on-year change?
What is Takeda Pharmaceutical Company Limited annual book value?
The current annual book value of TAK is $48.05 B
What is the all time high annual book value for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual book value is $48.05 B
What is Takeda Pharmaceutical Company Limited annual book value year-on-year change?
Over the past year, TAK annual book value has changed by +$366.77 M (+0.77%)
What is Takeda Pharmaceutical Company Limited quarterly book value?
The current quarterly book value of TAK is $48.46 B
What is the all time high quarterly book value for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly book value is $48.46 B
What is Takeda Pharmaceutical Company Limited quarterly book value year-on-year change?
Over the past year, TAK quarterly book value has changed by +$1.13 B (+2.39%)